ArticleJournal of clinical microbiology2013
Clinical significance of filamentous basidiomycetes illustrated by isolates of the novel opportunist Ceriporia lacerata from the human respiratory tract.
Article in Journal of clinical microbiology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
28 citing papers in PubMed, 42 citations in OpenAlex.
- A pilot study on the relationship between temperature and humidity and the detection of basidiomycetes in sputum from patients with chronic cough in the Nagasaki region.Journal of thoracic disease · 2026Article
- Emerging Filamentous Basidiomycetes as Opportunistic Human Pathogens: Diagnostic and Antifungal Challenges in a Tertiary-Care Center in Thailand.Antibiotics (Basel, Switzerland) · 2026Article
- The human mycobiome: a critical yet understudied component of health and disease.Microbiology (Reading, England) · 2025Review
- Pulmonary Infection Due toOpen forum infectious diseases · 2025Article
- Whole-genome sequencing and comparative genomic analysis ofMicrobial genomics · 2025Article
- Microbiome and Mycobiome Analyses of Continuous Positive Airway Pressure Devices.Clinical and experimental otorhinolaryngology · 2024Article
- The first suspected disseminatedEmerging microbes & infections · 2023Article
- Subcutaneous mycosis caused by filamentous basidiomyceteMedical mycology case reports · 2023Article
- The Fungal and Bacterial Interface in the Respiratory Mycobiome with a Focus onLife (Basel, Switzerland) · 2023Review
- Assessment of a novel continuous cleaning device using metatranscriptomics in diverse hospital environments.Frontiers in medical technology · 2023Article
- Dietary supplementation withFood science and biotechnology · 2021Article
- Clinical and etiological analysis of co-infections and secondary infections in COVID-19 patients: An observational study.The clinical respiratory journal · 2021Observational
- Hormographiella aspergillata: an emerging basidiomycete in the clinical setting? A case report and literature review.BMC infectious diseases · 2020Review
- Article
- Five Korean Cases of Respiratory Tract Infection by Filamentous Basidiomycetes.Annals of laboratory medicine · 2020Article
- Filamentous Fungi in Respiratory Infections. What Lies Beyond Aspergillosis and Mucormycosis?PLoS pathogens · 2016Review
- Subcutaneous abscess due to the basidiomycete Phellinus mori in a patient with chronic granulomatous disease.Infection · 2015Article
- Topographic diversity of the respiratory tract mycobiome and alteration in HIV and lung disease.American journal of respiratory and critical care medicine · 2015Article
- Article
- Prevalence and mechanism of triazole resistance in Aspergillus fumigatus in a referral chest hospital in Delhi, India and an update of the situation in Asia.Frontiers in microbiology · 2015Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors at 3 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The filamentous basidiomycete Ceriporia lacerata, an agent of white rot on wood, has never been reported in human disease and its clinical significance is not yet known. We describe 4 patients with respiratory diseases where C. lacerata was implicated in a wide spectrum of clinical manifestations ranging from saprobic colonization to fungal pneumonia. The isolates did not show the morphological characteristics that facilitate recognition of filamentous basidiomycetes, such as the presence of clamp connections, spicules along hyphae, or fruiting bodies. The identity of the mold was confirmed by sequencing the internal transcribed spacer 1 and 4 (ITS-1 and ITS-4) and D1/D2 regions of the rRNA gene. All of the isolates exhibited the lowest MICs of posaconazole and isavuconazole (MIC range, 0.06 to 0.125 μg/ml), followed by itraconazole (MIC range, 0.06 to 0.5 μg/ml), voriconazole (MIC range, 0.125 to 0.5 μg/ml), and amphotericin B (MIC range, 0.25 to 1 μg/ml). The infections reported here occurred in patients with preexisting lung damage induced by tuberculosis or chronic obstructive pulmonary disease. Chronic, sometimes fatal infections by the ascomycete Aspergillus fumigatus and the basidiomycete Schizophyllum commune are well established in the presence of an anatomical pulmonary defect or in the background of immunodeficiency. It is postulated that C. lacerata, a novel opportunist basidiomycete, may be involved in similar pathological processes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.